Literature DB >> 19138840

Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.

Yousif O Al-Bazz1, James C E Underwood, Barry L Brown, Pauline R M Dobson.   

Abstract

Apoptotic markers in breast cancer are reported to have prognostic significance. The aim of this study was to assess the prognostic value of Akt, phospho-Akt and BAD expression in primary tumours from breast cancer patients. Expression of phospho-Akt did not correlate with menopausal status, nodal involvement or tumour size, although there was a significant correlation between phospho-Akt and oestrogen receptor status and tumour grade. No association was found between phospho-Akt and BAD. However, a significant correlation was found between Akt and BAD. Akt and phospho-Akt expression did not correlate with either disease-free survival (DFS) or overall survival (OS). Conversely, BAD immunostaining correlated significantly with increasing tumour size and with oestrogen receptor (ER) immunostaining in both frozen and paraffin sections. Expression of BAD appeared to be nucleolar in addition to its cytoplasmic and nuclear staining. Comparison of immunohistochemical staining on frozen sections and paraffin sections showed a reasonable concordance in Akt and BAD immunoreactivity. However, the results showed for the first time that strong BAD expression is related to a favourable prognosis but is not an independent prognostic factor. In conclusion, these results could provide the basis for understanding how Akt, phospho-Akt and BAD expression contributes to the prognosis of invasive breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19138840     DOI: 10.1016/j.ejca.2008.11.044

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  18 in total

1.  Decrease of Bcl-xL/Bcl-2-associated death promoter in hepatocellular carcinoma indicates poor prognosis.

Authors:  Wen Hu; Jia Fu; Shi-Xun Lu; Li-Li Liu; Rong-Zhen Luo; Jing-Ping Yun; Chris Zhiyi Zhang
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

2.  Immunohistochemical detection of phospho-Akt, phospho-BAD, HER2 and oestrogen receptors alpha and beta in Malaysian breast cancer patients.

Authors:  Heng Fong Seow; Wai Kien Yip; Hui Woon Loh; Hairuszah Ithnin; Patricia Por; Mohammad Rohaizak
Journal:  Pathol Oncol Res       Date:  2009-11-01       Impact factor: 3.201

3.  Dysregulation of Rac or Rho elicits death of motor neurons and activation of these GTPases is altered in the G93A mutant hSOD1 mouse model of amyotrophic lateral sclerosis.

Authors:  Trisha R Stankiewicz; Claudia Pena; Ron J Bouchard; Daniel A Linseman
Journal:  Neurobiol Dis       Date:  2020-01-10       Impact factor: 5.996

4.  The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.

Authors:  Yaoyang Yu; Zhaokui Zhong; Yaowu Guan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  Loss of Bad expression confers poor prognosis in non-small cell lung cancer.

Authors:  Yi Huang; Dan Liu; Bojiang Chen; Jing Zeng; Lei Wang; Shangfu Zhang; Xianming Mo; Weimin Li
Journal:  Med Oncol       Date:  2011-09-15       Impact factor: 3.064

6.  Evaluating the Effects of Separate and Concomitant Use of MK-2206 and Salinomycin on Prostate Cancer Cell Line.

Authors:  Mohamadreza Savaee; Ali Bakhshi; Fatemeh Yaghoubi; Fatemeh Pourrajab; Koorosh Goodarzvand Chegini
Journal:  Rep Biochem Mol Biol       Date:  2022-04

7.  Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells.

Authors:  K S R Sastry; M A Al-Muftah; Pu Li; M K Al-Kowari; E Wang; A Ismail Chouchane; D Kizhakayil; G Kulik; F M Marincola; A Haoudi; L Chouchane
Journal:  Cell Death Differ       Date:  2014-09-12       Impact factor: 15.828

8.  Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.

Authors:  Isabel F Pinhel; Fiona A Macneill; Margaret J Hills; Janine Salter; Simone Detre; Roger A'hern; Ashutosh Nerurkar; Peter Osin; Ian E Smith; Mitch Dowsett
Journal:  Breast Cancer Res       Date:  2010-09-28       Impact factor: 6.466

9.  BRCA1/p220 loss triggers BRCA1-IRIS overexpression via mRNA stabilization in breast cancer cells.

Authors:  Yoshiko Shimizu; Nicole Mullins; Zannel Blanchard; Wael M Elshamy
Journal:  Oncotarget       Date:  2012-03

10.  BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer.

Authors:  Li Jiang; Man Luo; Dan Liu; Bojiang Chen; Wen Zhang; Lin Mai; Jing Zeng; Na Huang; Yi Huang; Xianming Mo; Weimin Li
Journal:  Cancer Cell Int       Date:  2013-06-01       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.